About KLIFO

The KLIFO history

KLIFO is a drug development consultancy and full-service Clinical Trial Supply with significant experience in partnering with pharmaceutical and biotech companies. We provide strategic advice and operational end-to-end solutions across the drug development journey. With years of dedication to their fields, our teams take pride in finding effective solutions and bringing that mindset into every client partnership

Get in contact
28_22112021

Our Story: Establishing Drug Development Consultancy

In the late 2000s, biotech innovation was booming—yet too many promising drugs never reached the market. Not because of the science, but because of execution: the wrong trials, the wrong strategies, the wrong designs.
Alejandra Mørk had seen this pattern again and again as a senior pharma executive.

“What was missing was someone who could see the full horizon.”
In 2008, she acquired KLIFO—not to take it over, but to reinvent it. The vision was clear: build a consulting house for pharmaceutical development, led by senior experts who could bridge strategy and execution.
“We’re not an army of junior consultants here to fill hours.
We’re the people who step in when it really matters.”
The approach worked. KLIFO grew steadily, not through sales, but through reputation. Clients came because they felt the difference—getting the right guidance at the right time, with a clear focus on approval.
As demand grew, so did KLIFO. New departments were added, and the company expanded into Germany, Sweden, and the Netherlands. In 2021, Gilde Healthcare invested—not to change KLIFO, but to scale what made it unique.
Today, KLIFO stands as a North European consultancy powerhouse, still driven by the same DNA:
➡️ Experts who understand the full spectrum of drug development
➡️ A true advisor and operator in one
A new management team has been established, while Alejandra Mørk continues adding value in her position as Strategic Development Advisor.

Meet the management team
Christina Vinum (1)

Our Story: Building Clinical Trial Supply

In clinical development, access to even the most promising therapy can fail if the clinical supply chain is not right. Not because of science, but because patients don’t get the right medicine, at the right time, in the right place and in the right condition.
That’s why KLIFO built its Clinical Trial Supply unit in 2008, spearheaded by Christina Vinum.

From the beginning, the vision was clear: bring together experts who understand every step of the supply chain—from packaging design and labelling, to distribution strategies and global logistics. The goal wasn’t just to move boxes, but to ensure that every supply chain decision supports the success of the trial itself.
“Supplying a clinical trial is not about packaging and shipments—it’s about enabling patients to participate safely, reliably, and on time.”
Over time, KLIFO’s CTS team grew into one of Europe’s most trusted partners. Known for flexibility, precision, and regulatory expertise, the unit became a lifeline for biotech and pharma companies navigating the complexity of international trials.
Today, Clinical Trial Supply at KLIFO is more than an operational service. It is a strategic partnership—anticipating risks, designing smart solutions, and ensuring that no trial is delayed due to lack of supply.
Because every patient deserves the chance to receive the right treatment—without compromise.

The KLIFO promise

Good medicines deserve to reach the market — but success requires more than science. It takes experience, regulatory maturity and flawless execution.

When you work with KLIFO, you get senior professionals who take ownership. We embed into your team, apply vertical insight, and ensure your drug product is developed, documented and delivered right.

Ready to address your clinical development needs?

Lets talk

Get in touch with KLIFO

Get in touch with us

Through collaboration, we can harness our combined expertise and ensure proper project implementation to ensure that your organisation benefits in both the short and long term.

Get in contact